Severe brain involvement in 5q spinal muscular atrophy type 0
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | MENDONCA, Rodrigo H. | |
dc.contributor.author | ROCHA, Antonio J. | |
dc.contributor.author | LOZANO-ARANGO, Andres | |
dc.contributor.author | DIAZ, Astry B. | |
dc.contributor.author | CASTIGLIONI, Claudia | |
dc.contributor.author | SILVA, Andre M. S. | |
dc.contributor.author | REED, Umbertina C. | |
dc.contributor.author | KULIKOWSKI, Leslie | |
dc.contributor.author | PARAMONOV, Ida | |
dc.contributor.author | CUSCO, Ivon | |
dc.contributor.author | TIZZANO, Eduardo F. | |
dc.contributor.author | ZANOTELI, Edmar | |
dc.date.accessioned | 2020-01-21T15:05:15Z | |
dc.date.available | 2020-01-21T15:05:15Z | |
dc.date.issued | 2019 | |
dc.description.abstract | Spinal muscular atrophy (SMA) type 0 is the most severe form of SMA, associated with the SMN1 gene and manifesting at birth. Most patients die in the first weeks of life. In this work, we present 3 patients with SMA type 0 who survived >1 year and presented diffuse and progressive brain abnormalities on magnetic resonance imaging, which are not usually seen in patients with SMA. Thus, severe brain involvement may likely be the full end manifestation of an already extreme SMA phenotype caused by substantial reduction of the SMN protein in the brain. ANN NEUROL 2019 | eng |
dc.description.index | MEDLINE | eng |
dc.identifier.citation | ANNALS OF NEUROLOGY, v.86, n.3, p.458-462, 2019 | |
dc.identifier.doi | 10.1002/ana.25549 | |
dc.identifier.eissn | 1531-8249 | |
dc.identifier.issn | 0364-5134 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/34443 | |
dc.language.iso | eng | |
dc.publisher | WILEY | eng |
dc.relation.ispartof | Annals of Neurology | |
dc.rights | restrictedAccess | eng |
dc.rights.holder | Copyright WILEY | eng |
dc.subject.other | werdnig-hoffmann disease | eng |
dc.subject.other | mouse model | eng |
dc.subject.other | spectrum | eng |
dc.subject.other | motor | eng |
dc.subject.other | sma | eng |
dc.subject.wos | Clinical Neurology | eng |
dc.subject.wos | Neurosciences | eng |
dc.title | Severe brain involvement in 5q spinal muscular atrophy type 0 | eng |
dc.type | article | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.affiliation.country | Espanha | |
hcfmusp.affiliation.country | Chile | |
hcfmusp.affiliation.countryiso | cl | |
hcfmusp.affiliation.countryiso | es | |
hcfmusp.author.external | ROCHA, Antonio J.:High Diagnost Excellence DASA Grp, Neuroradiol Sect, Sao Paulo, Brazil | |
hcfmusp.author.external | LOZANO-ARANGO, Andres:Hernan Henriquez Aravena Reg Hosp, Temuco, Chile | |
hcfmusp.author.external | DIAZ, Astry B.:Hernan Henriquez Aravena Reg Hosp, Temuco, Chile | |
hcfmusp.author.external | CASTIGLIONI, Claudia:Clin Las Condes, Dept Pediat Neurol, Santiago, Chile | |
hcfmusp.author.external | PARAMONOV, Ida:Valle Hebron Univ Hosp, Med Genet Grp, Valle Hebron Res Inst, Dept Clin & Mol Genet, Barcelona, Spain | |
hcfmusp.author.external | CUSCO, Ivon:Valle Hebron Univ Hosp, Med Genet Grp, Valle Hebron Res Inst, Dept Clin & Mol Genet, Barcelona, Spain | |
hcfmusp.author.external | TIZZANO, Eduardo F.:Valle Hebron Univ Hosp, Med Genet Grp, Valle Hebron Res Inst, Dept Clin & Mol Genet, Barcelona, Spain | |
hcfmusp.citation.scopus | 29 | |
hcfmusp.contributor.author-fmusphc | RODRIGO DE HOLANDA MENDONCA | |
hcfmusp.contributor.author-fmusphc | ANDRE MACEDO SERAFIM DA SILVA | |
hcfmusp.contributor.author-fmusphc | UMBERTINA CONTI REED | |
hcfmusp.contributor.author-fmusphc | LESLIE DOMENICI KULIKOWSKI | |
hcfmusp.contributor.author-fmusphc | EDMAR ZANOTELI | |
hcfmusp.description.beginpage | 458 | |
hcfmusp.description.endpage | 462 | |
hcfmusp.description.issue | 3 | |
hcfmusp.description.volume | 86 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 31301241 | |
hcfmusp.origem.scopus | 2-s2.0-85069928280 | |
hcfmusp.origem.wos | WOS:000480354400001 | |
hcfmusp.publisher.city | HOBOKEN | eng |
hcfmusp.publisher.country | USA | eng |
hcfmusp.relation.reference | Calucho M, 2018, NEUROMUSCULAR DISORD, V28, P208, DOI 10.1016/j.nmd.2018.01.003 | eng |
hcfmusp.relation.reference | Devriendt K, 1996, ANN NEUROL, V40, P731, DOI 10.1002/ana.410400509 | eng |
hcfmusp.relation.reference | Dubowitz V, 1999, Eur J Paediatr Neurol, V3, P49 | eng |
hcfmusp.relation.reference | Finkel R, 2015, NEUROMUSCULAR DISORD, V25, P593, DOI 10.1016/j.nmd.2015.04.009 | eng |
hcfmusp.relation.reference | Grotto Sarah, 2016, J Neuromuscul Dis, V3, P487 | eng |
hcfmusp.relation.reference | Harding BN, 2015, J NEUROPATH EXP NEUR, V74, P15, DOI 10.1097/NEN.0000000000000144 | eng |
hcfmusp.relation.reference | Ito Y, 2004, BRAIN DEV-JPN, V26, P53, DOI 10.1016/S0387-7604(03)00075-5 | eng |
hcfmusp.relation.reference | Jablonka S, 2006, HUM MOL GENET, V15, P511, DOI 10.1093/hmg/ddi467 | eng |
hcfmusp.relation.reference | LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3 | eng |
hcfmusp.relation.reference | Polido GJ, 2017, NEUROMUSCULAR DISORD, V27, P419, DOI 10.1016/j.nmd.2017.01.017 | eng |
hcfmusp.relation.reference | RudnikSchoneborn S, 1996, NEUROPEDIATRICS, V27, P8, DOI 10.1055/s-2007-973741 | eng |
hcfmusp.relation.reference | SHISHIKURA K, 1983, ACTA NEUROPATHOL, V60, P99, DOI 10.1007/BF00685353 | eng |
hcfmusp.relation.reference | Sugarman EA, 2012, EUR J HUM GENET, V20, P27, DOI 10.1038/ejhg.2011.134 | eng |
hcfmusp.relation.reference | Talbot K, 2017, GENE THER, V24, P529, DOI 10.1038/gt.2017.52 | eng |
hcfmusp.relation.reference | Tizzano EF, 2017, NEUROMUSCULAR DISORD, V27, P883, DOI 10.1016/j.nmd.2017.05.011 | eng |
hcfmusp.relation.reference | TOWFIGHI J, 1985, ACTA NEUROPATHOL, V65, P270, DOI 10.1007/BF00687008 | eng |
hcfmusp.relation.reference | Varghese Binoj, 2016, Indian J Radiol Imaging, V26, P316 | eng |
hcfmusp.relation.reference | von Gontard A, 2002, NEUROMUSCULAR DISORD, V12, P130, DOI 10.1016/S0960-8966(01)00274-7 | eng |
hcfmusp.relation.reference | Wishart TM, 2010, HUM MOL GENET, V19, P4216, DOI 10.1093/hmg/ddq340 | eng |
hcfmusp.relation.reference | YOHANNAN M, 1991, ACTA NEUROL SCAND, V84, P426, DOI 10.1111/j.1600-0404.1991.tb04982.x | eng |
hcfmusp.scopus.lastupdate | 2024-05-10 | |
relation.isAuthorOfPublication | 1c080b3e-ef89-4334-9f39-0905a6e4308c | |
relation.isAuthorOfPublication | accfe676-0727-49cd-8251-2262fa58d47a | |
relation.isAuthorOfPublication | cc9aed67-4ca0-4cc5-80be-c3e5fa74f07a | |
relation.isAuthorOfPublication | a248ef47-b0c3-4941-ba03-78adb1cf4766 | |
relation.isAuthorOfPublication | 61bd9026-929a-4d06-a8ee-0445b8703e69 | |
relation.isAuthorOfPublication.latestForDiscovery | 1c080b3e-ef89-4334-9f39-0905a6e4308c |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- art_MENDONCA_Severe_brain_involvement_in_5q_spinal_muscular_atrophy_2019.PDF
- Tamanho:
- 531.44 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)